Company profile: Asymchem
1.1 - Company Overview
Company description
- Provider of CDMO and pharmaceutical manufacturing services and biotech solutions, focused on R&D of pharmaceutical raw materials synthesis technology applied to drug development and production, supporting efficient, flexible processes and accelerating the commercial launch of biotech products.
Products and services
- CDMO Services: Asymchem delivers CDMO services, leveraging pharmaceutical raw materials synthesis R&D to support biotech and pharmaceutical companies in drug development and production, custom-engineered for scalability
- Pharmaceutical Manufacturing Services: Asymchem supplies manufacturing services for pharmaceutical companies with efficient and flexible production processes applied to drug development and production, industrial-grade for reliable throughput
- Biotech Solutions: Asymchem offers comprehensive systems that accelerate the commercial launch of biotech products for large and medium-sized pharmaceutical companies, modular to streamline scale-up from development to production
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Asymchem
Eurofins
HQ: Luxembourg
Website
- Description: Provider of analytical testing and support services across pharmaceutical, food, environmental, and consumer products industries, including clinical diagnostics (sample collection, testing, counseling), environmental testing of water, air, soil and waste, cosmetics and personal care compliance testing, E&E product safety and approvals, maritime pollution and fuel/oil testing, and microbiological testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurofins company profile →
Genflow Biosciences
HQ: United States
Website
- Description: Provider of synthetic biology-based gene therapies to delay or stop aging in humans and dogs, focused on the development and promotion of creative treatments that target aging to extend life expectancy in both humans and canines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genflow Biosciences company profile →
McKesson
HQ: United States
Website
- Description: Provider of pharmaceutical distribution (branded, generic, OTC) to healthcare providers; wholesale medical supplies and equipment; pharmacy management tools and consulting; specialty practice solutions including value-based care, group purchasing, and EHR; biopharma commercialization, medication access and adherence programs; and biosimilars.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full McKesson company profile →
Biorasi
HQ: United States
Website
- Description: Provider of contract research services for complex clinical trials, offering safety and pharmacovigilance (medical coding, case processing, data monitoring, safety management, annual reporting), clinical trial rescue (patient recruitment, site activation, logistical coordination), CAR T-cell therapy trial management (cell collection, modification, reinfusion), and precision medicine through pharmacogenomics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biorasi company profile →
Phasex
HQ: United States
Website
- Description: Provider of supercritical CO2 extraction for natural products, primarily serving the natural products, biopharmaceuticals, and polymers market segments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phasex company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Asymchem
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Asymchem
2.2 - Growth funds investing in similar companies to Asymchem
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Asymchem
4.2 - Public trading comparable groups for Asymchem
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →